Russell Sass

Representative Matters:

• Advised a national provider of physician services in the divestiture of its radiology and teleradiology business and anesthesiology business
• Advised a leading provider of minimally invasive spine services operating a network of ambulatory surgery centers and physician practices in the southeastern United States, on its acquisition by a New York-based private equity firm
• Advising a New York based Medicaid value-based network of independent physician associations and managements services organizations focusing on ensuring access to care and improving health outcomes and the largest participant in New York’s Innovator VBP Program
• Advised a specialty pharmacy in divesting certain pharmacy assets to CVS Pharmacy
• A prominent California-based cancer treatment practice, in a complex acquisition of the business by a private equity firm focused in the healthcare space
• Designed a DSO joint venture in connection with growth initiatives for dentist alignment strategy culminating in successful leveraged buyout to a private equity firm
• Advised a Nasdaq-listed technology-enabled provider of value-based healthcare in its acquisition of the value-based Medicare business of a leading hospital system that covered nearly 200,000 patients across the country
• Assisted client in its nearly US$600 million acquisition of the assets from a pharmacy benefit management services business
• Represented multi-state health systems with respect to affiliation models, strategic reorganizations, managed care contracting and value-based payment arrangements, including for affiliated clinically integrated networks (CINs), accountable care organizations (ACOs), and other provider organizations
• Assisted in establishing or acquiring/selling insurance companies and health maintenance organizations or otherwise assisting with regulation filings and compliance matters
• Represented New Jersey Urology, the leading urology service provider in New Jersey, in its partnership and restructuring with J.W. Childs Associates, a leading middle-market private equity firm, in forming Urology Management Associates that provides administrative services to NJU
• Represented North American Dental Group in its acquisition of multiple dental clinics
• Represented Abry Partners in its acquisition of Dr. Dental
• Represented ROARK in its acquisition of Great Expression Dental Centers
• Represented Warburg Pincus in the acquisition of CityMD, a New York and New Jersey based urgent care provider
• Currently representing private equity fund in acquisition of New York based population health management platform
• Currently representing private equity fund in acquisition of New York based walk-in clinics/medical practice
• Represented Gastro Health in its partnership and restructuring with The Audax Group
• Represented Prairie Capital in its sale of  Riverchase Dermatology & Cosmetic Surgery to GTCR
• Currently representing large dermatology platform in partnership with private equity fund
• Represented Skin and Cancer Associates LLP in the sale of its partnership interests to SPC Dermatology Partners, LLC
• Represented Advanced Surgery Center in connection with its partnership with Surgery Partners, Inc.
• Currently representing New York based dental health insurance platform in connection with its sale to a national competitor
• Represented Fulcrum Equity in its acquisition of CarePlus Medical
• Represented Fulcrum Equity in its acquisition of Liberation Way